InvestorsHub Logo
Followers 57
Posts 5697
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Saturday, 11/17/2018 2:37:37 PM

Saturday, November 17, 2018 2:37:37 PM

Post# of 1190
This is one of the most interesting oncology plays in my opinion. They have a very productive platform and many drugs in the clinic...some with very good results (these are the guys who developed the great adjuvant that makes Shingrix so powerful!). I understand they are looking at two partnerships. I have often thought that if they had two BP's interested in their assets the partnering dance might end up in a bidding war and a buyout offer. It would be multi-billions but some company who wanted to become an oncology powerhouse over the next few years could find it all in the Agenus platform and portfolio. I can see why the current management might want to keep control of all these assets...only an offer too good to refuse could end in buyout IMO.

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AGEN News